Marko Jakopović
Impact in
- Oncology top 2%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances
- Pneumonia and Respiratory Infections
Papers in
-
- Lung Cancer Treatments and Mutations 19
- Lung Cancer Diagnosis and Treatment 12
- Occupational and environmental lung diseases 11
- Medical Imaging and Pathology Studies 7
- Chronic Obstructive Pulmonary Disease (COPD) Research 6
- Oncology 28
- Lung Cancer Research Studies 13
- Cancer Immunotherapy and Biomarkers 10
- Co-authors
- Miroslav Samaržija (51 shared papers)Anish Thomas (5 shared papers)Giuseppe Giaccone (3 shared papers)Yuanbin Chen (1 shared paper)Davor Tomas (1 shared paper)Mateja Janković Makek (12 shared papers)Neven Žarković (1 shared paper)Marija Poljak‐Blaži (1 shared paper)
In The Last Decade
Marko Jakopović
101 papers receiving 3.5k citations
Marko Jakopović's Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 1.6k
- Epidemiology 1.0k
- Pulmonary and Respiratory Medicine 962
- Cancer Research 362
- Molecular Biology 979
Countries citing papers authored by Marko Jakopović
This map shows the geographic impact of Marko Jakopović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Jakopović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Jakopović more than expected).
Fields of papers citing papers by Marko Jakopović
This network shows the impact of papers produced by Marko Jakopović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Jakopović. The network helps show where Marko Jakopović may publish in the future.
Co-authors
The 25 scholars most cited alongside Marko Jakopović, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive genomic profiles of small cell lung cancer Hit paper breakdown → | 2015 | 1818 |
| 2 | 2018 | 164 | |
| 3 | 2016 | 134 | |
| 4 | 2019 | 118 | |
| 5 | 2005 | 107 | |
| 6 | 2015 | 96 | |
| 7 | 2021 | 86 | |
| 8 | 2013 | 60 | |
| 9 | 2013 | 59 | |
| 10 | 2014 | 56 | |
| 11 | 2015 | 50 | |
| 12 | 2020 | 43 | |
| 13 | 2016 | 38 | |
| 14 | 2015 | 35 | |
| 15 | 2005 | 31 | |
| 16 | 2020 | 30 | |
| 17 | 2020 | 30 | |
| 18 | 2015 | 29 | |
| 19 | 2014 | 27 | |
| 20 | 2018 | 27 |
About Marko Jakopović
Marko Jakopović is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Cancer Research and Neurology, having authored 108 papers that have together received 3.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (13 papers), Lung Cancer Diagnosis and Treatment (12 papers), Occupational and environmental lung diseases (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Medical Imaging and Pathology Studies (7 papers), Mycobacterium research and diagnosis (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). The work is most often cited by research in Oncology (1.6k citations), Epidemiology (1.0k citations), Pulmonary and Respiratory Medicine (962 citations), Cancer Research (362 citations) and Molecular Biology (979 citations). Marko Jakopović has collaborated with scholars based in Croatia, Austria and Germany. Frequent co-authors include Miroslav Samaržija, Anish Thomas, Giuseppe Giaccone, Yuanbin Chen, Davor Tomas, Mateja Janković Makek, Neven Žarković, Marija Poljak‐Blaži, Maja Prutki and Luka Brcic. Their work appears in journals such as Translational Lung Cancer Research, Journal of Thoracic Oncology, Annals of Oncology, International Journal of Molecular Sciences and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.